Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pamiparib in HER2-negative BRCA-mutated breast cancer
NCT03575065Phase 2Completed
- Sponsor
- BeiGene
- Start
- Jun 2018
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pamiparib in breast cancer, sponsored by BeiGene. Started Jun 2018; status: completed.
02
Drugs
pamiparib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03575065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03575065.